期刊文献+

抗CD44单克隆抗体IM7在体外诱导慢性髓系白血病干/祖细胞的凋亡 被引量:2

Apoptosis of Chronic Myeloid Leukemia Stem/Progenitor Cells Induced by Anti-CD44 Monoclonal Antibody IM7 In Vitro
下载PDF
导出
摘要 本研究探讨抗CD44单克隆抗体IM7在体外诱导慢性髓系白血病干/祖细胞(leukemic stem/progenitor cells,LSPC)凋亡情况及其可能的作用机制。取20例初诊的慢性髓系白血病(chronic myeloid leukemia,CML)病人骨髓液5-10ml,用免疫磁株分离法分离出CD34+、CD38-、CD123+LSPC。利用Annexin-V试剂盒检测IM7诱导CML-LSPC凋亡情况;荧光实时定量PCR及RT-PCR检测CML-LSPC中原癌基因c-myc、NF-κB表达水平;Western-blot检测IM7孵育后CML-LSPC中BCL-2蛋白表达变化。结果表明:经IM7孵育后CML-LSPC的早期凋亡率由对照组(5.42±1.84)(升高至(12.58±2.84)((p<0.05)。IM7孵育后CML-LSPC中原癌基因c-myc、NF-κB mRNA表达水平明显降低,IM7能有效抑制CML-LSPC中BCL-2蛋白表达下调,CML-LSPC中NF-κB的活性受到抑制。结论:抗CD44单克隆抗体IM7能有效诱导CML-LSPC凋亡,其可能机制为NF-κB的活性降低,作为下游靶基因c-myc及bcl-2表达下调,从而诱导LSPC凋亡。 The aim of this study was to investigate the apoptosis-inducing effect of anti-CD44 monoclonal antibody IM7 on chronic myeloid leukemia (CML) stem/progenitor cells in vitro and to explore its possible mechanism. Leukemic stem/progenitor cells ( LSPCs ) expressing CD34 ^+ , CD38 - and CD123 ^+ were isolated from bone marrow (BM) cells of 20 patients with newly-diagnosed chronic myeloid leukemia by using EasySepTM magnetic beads. The percentage of apoptotic CML-LSPCs was assayed by Annexin-V/PI staining; the expression changes of c-myc and NF- KB mRNA were detected by real-time quantitative PCR(RQ-PCR) and RT-PCR; the NF-KB activity was detected by NF-KB Activation Nuclear Translocation Assay Kit; the BCL-2 protein expression was determined in the Western blot method. The results showed that the IM7 effectively induced apoptosis of CML-LSPCs; the mean percentage of early apoptotic cells significantly increased, as compared with the untreated control CML-LSPCs cells 12.58 ± 2.84% vs 5.42 ±1.84% (p 〈 0.05 ). The c-myc , NF-KB mRNA expressions were down -regulated as compared with the control group (0.65 ±0. 10 vs 1. (90, 0.42 ±0.21 vs 1.00, respectively) (p 〈0.01 ) by RQ-PCR and (0.49 ±0.09 vs 0. 60 ± 0.12, 0.47 ± 0.11 vs 0. 67 ± 0.08, respectively ) (p 〈 0.01 ) by RT-PCR. The BCL-2 protein level in CML-LSPCs treated with 1M7 also decreased as compared with the control group (p 〈0.01 ). In addition, the depression of NF-KB activity was observed through fluorescence microscope. It is concluded that the anti-CD44 monoclonal antibody IM7 effectively induces apoptosis of CML-LSPCs through down-regulating c-myc and bcl-2 mRNA expression, and decreasing NF-KB activity in CML-LSPCs.
出处 《中国实验血液学杂志》 CAS CSCD 2010年第3期601-605,共5页 Journal of Experimental Hematology
基金 国家自然科学基金项目(编号30470733)(30770916)
关键词 抗CD44单克隆抗体 IM7 慢性髓系白血病 白血病干/祖细胞 anti-CD44 monoclonal antibody IM7 chronic myeloid antibody leukemia stem/progenitor cell
  • 相关文献

参考文献16

  • 1Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature, 2001 ; 414(6859) :105 - 111.
  • 2Domen J, Weissman IL. Self-renewal, differentiation or death : regulation and manipulation of hematopoietic stem cell fate. Mol Med Today, 1999;5(5) :201 -218.
  • 3Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell, 2000; 100( 1 ) : 157 - 168.
  • 4Weissman IL. Translating stem and progenitor cell biology to the clinic : barriers and opportunities. Science, 2000 ; 287 ( 5457 ) : 1442 - 1446.
  • 5Ghaffari S, Smadja-Joffe F, Oostendorp R, et al. CD44 isoforms in normal and leukemic hematopoiesis. Exp Hematol, 1999; 27 (6) : 978 -993.
  • 6Parisi E, Draznin J, Stoopler E, et al. Acute myelogenous leukemia:advances and limitations of treatment, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2002 ; 93 (3) : 257 - 263.
  • 7Wang ZY. Ham-wasserman lecture : treatment of acute leukemia by inducing differentiation and apoptosis. Hematology Am Soc Hematol Educ Program, 2003 : 1 - 13.
  • 8Ponta H, Sherman L, Herrlich PA. CD44 : from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol, 2003 ; 4 (1) : 33 -45.
  • 9Streuli C. Extracellular matrix remodeling and cellular differntiation. Curr Opin Cell Biol, 1999; 11(5) :634 -640.
  • 10Charrad RS, Gadhouln Z, Qi J, et al. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines. Blood, 2002 ; 99 ( 1 ) : 290 - 299.

二级参考文献30

  • 1王雅丹,胡豫,孙春艳.姜黄素抑制多发性骨髓瘤细胞脑源性神经营养因子所诱导的血管新生作用[J].中国实验血液学杂志,2006,14(1):70-74. 被引量:5
  • 2刘元华,Christophe Leboeuf,金晓龙,肖家诚,Anne Janin,陈赛娟,赵维莅.非霍奇金淋巴瘤BCL-XL基因表达及突变的研究[J].中国实验血液学杂志,2006,14(5):903-907. 被引量:1
  • 3Thomas RK, Re D,Wolf J,et al. Part 1 : Hodgkin's lymphoma molecular biology of Hodgkin and Reed-Steinberg cells. Lancet Oncol, 2004;5:11 -18
  • 4Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequence. Cell, 1986;46:705 -716
  • 5Birkenkamp KU,Geugien M , Schepers H,et al. Constitutive NF-kappaB DNA-binding activity in AML is frequently mediated by a Ras/ P13-K/PKB-dependent pathway. Leukemia, 2004 ; 18 : 103 - 112
  • 6Kirchner D, Duyster J, Ottinann O,et al. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation. Exp Hematol,2003 ;31:504 - 511
  • 7Ryan KM, Ernst MK, Rice NR, et al. Role of NF-kappaB in p53- mediated programmed cell death. Nature, 2000; 404(6780) :892 - 897
  • 8Rocha S, Martin AM, Meek DW, et al. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol,2003 ;23:4713 -4727
  • 9Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-kappaB transactivation by the ARF tumor suppressor. Mol Cell, 2003;12:15 -25
  • 10Dreyfus DH, Nagasawa M, Gelfand EW, et al. Modulation of p53 activity by 1κBα : evidence suggesting a common phylogeny between NF-κB and p53 transcription factors. BMC Immunol. 2005; 6:12

共引文献6

同被引文献77

  • 1蔡华荣,江跃全.多肽修饰载紫杉醇脂质体靶向A549肺癌干细胞的研究[J].中国生化药物杂志,2014,34(4):11-14. 被引量:5
  • 2Pigneux A, MahonFX, Moreau-Gaudry F, et al. Proteasome inhibi- tion specifically sensitizes leukemic cells to anthracyclin-induced apoptosis through the accumulation of Bim and Bax pro-apoptotic proteins. Cancer Bid Ther, 2007, 6(4) : 603-611.
  • 3Attar EC, De Angelo DJ, Supko JG, et al. Phase I and pharmacoki- netic study of bortezomib in combination with idarubiein and cytara- bine in patients with acute myelogenous leukemia. Clin Cancer Res, 2008, 14(5): 1446-1454.
  • 4Skubitz A P N, Taras E P, Boylan K L M, et al. Targeting CD133 in an in vivo ovarian cancer model reduces ovarian cancer progression[J].Gynecol Oncol, 2013, 130(3): 579-587.
  • 5Chen J, Liu Q M, Xiao J G, et al. EpCAM-antibody-labeled non cytotoxic polymer vesicles for cancer stem cells-targeted delivery of anticancer drug and siRNA[J]. Biomacromolecules, 2015, 16 (6): 1695-1705.
  • 6Lawson D A, Bhakta N R, Kessenbrock K, et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells[J].Nature, 2015, 526: 131-135.
  • 7Yang Y, Fan Y X, Qi Y, et al. Side population cells separated from A549 Lung cancer cell line possess cancer stem cell-like properties and inhibition of autophagy potentiates the cytotoxic[J]. Oncol Rep, 2015,34(2): 929-935.
  • 8Iacopino F, Angelucci C, Piacentini R, et al. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones[J]. PloS One, 2014, 9(8): e105166.
  • 9Takaishi S, Okumura T, Tu S P, et al. Identification of gastric cancer stem cells using the cell surface marker CD44[J]. Stem Cells, 2009,27(5): 1006-1020.
  • 10Du L, Rao G H, Wang H Y, et al. CD44-positive cancer stem cells expressing cellular prion protein contribute to metastatic capacity in colorectal cancer[J]. Cancer Res, 2013, 73(8): 2682-2694.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部